Evidence map›Paper›PMID 42784722›Full record

ArticleJournal of leukocyte biology2026

Δ9-Tetrahydrocannabinol exposure shifts eosinophil and macrophage transcriptional programs toward an anti-inflammatory phenotype in helminth infection.

Jennell Jennett, Martin Olmos, Ka Man Lam, Sarah Midou, Nicholas V DiPatrizio, Meera G Nair

Abstract read
In one paragraph

Article in Journal of leukocyte biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

  • Update of
    Δ2026
5 · Who and what money

Authors and funding

6 authors.

Jennell JennettDivision of Biomedical Sciences, School of Medicine, University of California Riverside, 900 University Avenue, Riverside, CA 92521, United States.
Martin OlmosDivision of Biomedical Sciences, School of Medicine, University of California Riverside, 900 University Avenue, Riverside, CA 92521, United States.ORCID 0009-0009-9325-9524
Ka Man LamDivision of Biomedical Sciences, School of Medicine, University of California Riverside, 900 University Avenue, Riverside, CA 92521, United States.ORCID 0009-0000-7469-1818
Sarah MidouDivision of Biomedical Sciences, School of Medicine, University of California Riverside, 900 University Avenue, Riverside, CA 92521, United States.ORCID 0009-0008-3724-7812
Nicholas V DiPatrizioDivision of Biomedical Sciences, School of Medicine, University of California Riverside, 900 University Avenue, Riverside, CA 92521, United States.
Meera G NairDivision of Biomedical Sciences, School of Medicine, University of California Riverside, 900 University Avenue, Riverside, CA 92521, United States.ORCID 0000-0002-1807-5161

Funding

RELMalpha-expressing macrophages mediate host disease tolerance in mucosal infectionR01AI153195 · NIAID · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI NAIR, MEERA GOH · 2020 to 2024
$3.5M
Sex-dependent innate immune mechanisms in type 2 immunity and obesityR01AI191470 · NIAID · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI Meera Goh Nair · 2025 to 2026
$1.4M
Innate immune pathways underlying sexual dimorphism in obesity pathogenesisR21AI180561 · NIAID · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI COSS, DJURDJICA, NAIR, MEERA GOH · 2024 to 2025
$407k
California Institute of Regenerative Medicine EDUC5-13636NIAID NIH HHS R01 AI153195NIAID NIH HHS R01 AI191470NIAID NIH HHS R21 AI180561NIH HHS R01AI153195NIH HHS R01AI191470NIH HHS R21AI180561
6 · The paper itself

Abstract

Cannabis use is increasing globally, yet the immunological effects of Δ9-tetrahydrocannabinol, the main intoxicating component of cannabis, remain incompletely understood. Given prior evidence that endocannabinoid signaling influences helminth immunity and type 2 inflammation, we investigated how sustained Δ9-tetrahydrocannabinol exposure alters immune responses to the helminth Nippostrongylus brasiliensis, which infects the lung and small intestine of mice. C57BL/6J mice were treated with Δ9-tetrahydrocannabinol (5 mg/kg/d) or vehicle for 14 d prior to helminth infection and assessed for parasite burden, innate immune cell and T cell responses, and transcriptional changes in lung eosinophils and macrophages. Δ9-Tetrahydrocannabinol exposure did not significantly alter infection-associated weight loss or helminth burden; however, Δ9-tetrahydrocannabinol selectively restrained infection-induced circulating eosinophils and monocytes while increasing regulatory T cells. T cell activation assays showed reduced TNFα and IFNγ secretion in splenocytes from Δ9-tetrahydrocannabinol-treated infected mice. Bulk RNA sequencing showed that Δ9-tetrahydrocannabinol shifted lung eosinophils and CD11c+ lung macrophage-enriched cells from inflammatory, fibrotic, and costimulatory pathways toward stress and metabolic-adaptive transcriptional programs. Within the infected macrophage-enriched population, Δ9-tetrahydrocannabinol reduced CD80 expression while increasing MHC class II and antigen presentation-associated genes, suggesting a potential shift in macrophage-mediated T cell activation. Consistent with altered inflammatory and tissue remodeling-associated programs, immunofluorescent staining showed that Δ9-tetrahydrocannabinol mitigated infection-associated loss of lung collagen. Collectively, these findings indicate that Δ9-tetrahydrocannabinol reshapes the immune response to helminth infection by restraining innate and T cell effector responses while altering lung eosinophil and macrophage activation programs.

Indexed as

Anti-Inflammatory AgentsDronabinolEosinophilsMacrophagesNippostrongylusStrongylida InfectionsTranscription, GeneticAnimalsLungMaleMiceMice, Inbred C57BLPhenotypeAnti-Inflammatory AgentsDronabinoleosinophilshelminth infectionmacrophagesTHCtype 2 inflammation

Identifiers

PMID42784722
PMCPMC13653213

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.